SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Lahariya C, Pradhan SK.Emergence of chikungunya virus in Indian subcontinent after 32 years: a review.J Vect Borne Dis2006;43:15160.
  • 2
    Thiboutot MM, Kannan S, Kawalekar OU, Shedlock DJ, Khan AS, Sarangan G, et al.Chikungunya: a potentially emerging epidemic?PLoS Negl Trop Dis2010;4:e623.
  • 3
    Chopra A, Anuradha V, Ghorpade R, Saluja M.Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study.Epidemiol Infect2012;140:84250.
  • 4
    Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M.Chikungunya virus aches and pains: an emerging challenge.Arthritis Rheum2008;58:29212.
  • 5
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al.The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials.Arthritis Rheum1993;36:72940.
  • 6
    Chopra A, Saluja M.Validation and usefulness of Indian version (CRD Pune) health assessment questionnaire: drug trials, community practice and COPCORD Bhigwan population study (1994-2012).Indian J Rheumatol2012;7:7482.
  • 7
    Joshi VL, Chopra A.Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model.J Rheumatol2009;36:61422.
  • 8
    Meyer PW, Hodkinson B, Ally M, Musenge E, Wadee AA, Fickl H, et al.Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.Mediators Inflamm2010;2010:158514.
  • 9
    Brighton SW.Chloroquine phosphate treatment of chronic Chikungunya arthritis: an open pilot study.S Afr Med J1984;66:2178.
  • 10
    Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R.Effects of chloroquine on viral infections: an old drug against today's diseases?Lancet Infect Dis2003;3:7227.
  • 11
    Ozden S, Lucas-Hourani M, Ceccaldi PE, Basak A, Valentine M, Benjannet S, et al.Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein.J Biol Chem2008;8:21899908.
  • 12
    Tang BL.The cell biology of Chikungunya virus infection.Cell Microbiol2012;14:135463.
  • 13
    Wozniacka A, Lesiak A, Narbutt J, McCauliffe DP, Sysa-Jedrzejowska A.Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.Lupus2006;15:26875.
  • 14
    US National Institutes of Health. CuraChik: a trial of the efficacy and safety of chloroquine as therapeutic treatment of Chikungunya. October2008. ClinicalTrials.gov URL: http://clinicaltrials.gov/ct2/show/NCT00391313.
  • 15
    De Lamballerie X, Boisson V, Reynier JC, Ernault S, Charrel RN, Fiahault A, et al.On chikungunya acute infection and chloroquine treatment.Vector Borne Zoonotic Dis2008;8:8379.
  • 16
    Padmakumar B, Jayan JB, Menon RM, Krishnankutty B, Payippallil R, Nisha RS.Comparative evaluation of four therapeutic regimens in Chikungunya arthritis: a prospective randomized parallel group study.Indian J Rheumatol2009;4;94101.
  • 17
    Pandya S.Methotrexate and hydroxychloroquine combination therapy in chronic Chikungunya arthritis: a 16 week study.Indian J Rheumatol2008;3:937.
  • 18
    Chopra A, Venugopalan A.Persistent rheumatic musculoskeletal pain and disorders at one year post-Chikungunya epidemic in south Maharashtra: a rural community based observational study with special focus on naive persistent rheumatic musculoskeletal cases and selected cytokine express.Indian J Rheumatol2011;6:511.
  • 19
    Tokayer A, Carsons SE, Chokshi B, Santiago-Schwarz F.High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.J Rheumatol2002;29:45461.
  • 20
    Couderc T, Chretien F, Schilte C, Disson O, Brugitte M, Guivel-Benhassine F, et al.A mouse model for Chikungunya: young age and inefficient type-1 interferon signaling are risk factors for severe disease.PLoS Pathog2008;4:e29.
  • 21
    Labadie KT, Larcher C, Joubert A, Mannioui B, Delache P, Brochard L, et al.Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.J Clin Invest2010;120:894906.
  • 22
    Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P, et al.Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.PLoS Negl Trop Dis2012;6:e1446.
  • 23
    Suhrbier A, Jaffar-Bandjee MC, Gasque P.Arthritogenic alphaviruses: an overview.Nat Rev Rheumatol2012;8:4209.